Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma


A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

‘Quordle’ today: Here are the answers and hints for December 12

Previous article

WhatsApp is working on ‘view once’ messages

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News